Skip to main content

Table 1 Biochemical and serologic features of clinical subjects

From: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models

Subject Age (years) Gender suPAR (ng/ml) uPA (ng/ml) Creatinine (mg/dl) Up/UCr
MCD 36.00 ± 4.25 3 F/19 M 2.03 ± 0.18 0.44 ± 0.15 1.13 ± 0.26 7.7 ± 0.03
FSGS 56.83 ± 8.29 4 F/14 M 3.67 ± 0.17* 0.1 ± 0.02* 3.42 ± 1.41* 8.92 ± 4.12
  1. uPA urokinase-type plasminogen activator, suPAR soluble uPA receptor. * p<0.05 vs. MCD